Project Details
Description
Vascular diseases stand as the third leading cause of cardiovascular death globally. Direct oral anticoagulants (DOACs) emerge as a suitable therapeutic option in cardiovascular diseases such as non-valvular atrial fibrillation (NVAF) and venous thromboembolism (VTE) with recognized clinical and epidemiological impact.
Objective
To describe the patterns of prescription of direct oral anticoagulants (DOACs) in adult patients treated at Méderi University Hospital
Key findings
We aim to describe the use of direct oral medications in a high complexity hospital based on updated clinical practice guidelines and to introduce strategies for the proper prescription, follow-up, control, and surveillance of DOACs.
| Status | Active |
|---|---|
| Effective start/end date | 28/02/24 → 28/12/25 |
UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):
Keywords
- direct oral anticoagulants
- Prescription Patterns
Mederi Institutes
- Adult Haematology Institute
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.